Mortality associated with neurofibromatosis 1: A cohort study of 1895 patients in 1980-2006 in France

89Citations
Citations of this article
87Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Neurofibromatosis 1 (NF1), a common autosomal dominant disorder, was shown in one study to be associated with a 15-year decrease in life expectancy. However, data on mortality in NF1 are limited. Our aim was to evaluate mortality in a large retrospective cohort of NF1 patients seen in France between 1980 and 2006. Methods. Consecutive NF1 patients referred to the National French Referral Center for Neurofibromatoses were included. The standardized mortality ratio (SMR) with its 95% confidence interval (CI) was calculated as the ratio of observed over expected numbers of deaths. We studied factors associated with death and causes of death. Results: Between 1980 and 2006, 1895 NF1 patients were seen. Median follow-up was 6.8 years (range, 0.4-20.6). Vital status was available for 1226 (65%) patients, of whom 1159 (94.5%) survived and 67 (5.5%) died. Overall mortality was significantly increased in the NF1 cohort (SMR, 2.02; CI, 1.6-2.6; P < 10-4). The excess mortality occurred among patients aged 10 to 20 years (SMR, 5.2; CI, 2.6-9.3; P < 10-4) and 20 to 40 years (SMR, 4.1; 2.8-5.8; P < 10-4). Significant excess mortality was found in both males and females. In the 10-20 year age group, females had a significant increase in mortality compared to males (SMR, 12.6; CI, 5.7-23.9; and SMR, 1.8; CI, 0.2-6.4; respectively). The cause of death was available for 58 (86.6%) patients; malignant nerve sheath tumor was the main cause of death (60%). Conclusions: We found significantly increased SMRs indicating excess mortality in NF1 patients compared to the general population. The definitive diagnosis of NF1 in all patients is a strength of our study, and the high rate of death related to malignant transformation is consistent with previous work. The retrospective design and hospital-based recruitment are limitations of our study. Mortality was significantly increased in NF1 patients aged 10 to 40 years and tended to be higher in females than in males. © 2011 Duong et al; licensee BioMed Central Ltd.

Figures

  • Figure 1 Flow chart of the vital status of patients with NF1 cohort seen between 1980 and 2005.
  • Table 1 Characteristics of the NF1 patients according to whether their vital status was known or unknown
  • Table 2 Characteristics of the survivors and nonsurvivors among the 1226 NF1 patients whose vital status was known
  • Table 3 Number of deaths (n) and SMRs among the NF1 patients by age group
  • Table 4 Number of deaths (n) and SMRs among the NF1 patients, by age categories (years), by sex

References Powered by Scopus

Long-Term Follow-up of von Recklinghausen Neurofibromatosis

502Citations
N/AReaders
Get full text

A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I Prevalence, fitness, mutation rate, and effect of parental transmission on severity

479Citations
N/AReaders
Get full text

Mortality in neurofibromatosis 1: An analysis using U.S. death certificates

435Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Neurofibromatosis type 1

571Citations
N/AReaders
Get full text

Distinctive cancer associations in patients with neurofibromatosis type 1

278Citations
N/AReaders
Get full text

Incidence and mortality of neurofibromatosis: A total population study in Finland

205Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Duong, T. A., Sbidian, E., Valeyrie-Allanore, L., Vialette, C., Ferkal, S., Hadj-Rabia, S., … Wolkenstein, P. (2011). Mortality associated with neurofibromatosis 1: A cohort study of 1895 patients in 1980-2006 in France. Orphanet Journal of Rare Diseases, 6(1). https://doi.org/10.1186/1750-1172-6-18

Readers over time

‘11‘12‘13‘14‘15‘16‘17‘18‘19‘20‘21‘22‘23‘24‘25036912

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 25

60%

Researcher 11

26%

Professor / Associate Prof. 6

14%

Readers' Discipline

Tooltip

Medicine and Dentistry 36

71%

Biochemistry, Genetics and Molecular Bi... 7

14%

Agricultural and Biological Sciences 6

12%

Pharmacology, Toxicology and Pharmaceut... 2

4%

Article Metrics

Tooltip
Mentions
News Mentions: 1
References: 3

Save time finding and organizing research with Mendeley

Sign up for free
0